Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Development
  6.  » A Collaborative Effort: How Parallel Approaches and Diverse Partnerships Could Help Combat COVID-19

A Collaborative Effort: How Parallel Approaches and Diverse Partnerships Could Help Combat COVID-19

Summary: The COVID-19 virus is arguably the most challenging global healthcare crisis of our time. In a panel discussion moderated by John Carroll, Editor & Founder of Endpoints News, executives from Moderna, Sanofi Pasteur, Takeda and Catalent shared behind-the-scenes updates on their respective efforts to develop a COVID-19 vaccine. While their approaches are different, the companies have all adopted a collaborative mindset to arrive at a vaccine as quickly and safely as possible.

 

Click here to download the Article